Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Our portfolio companies benefit from the full global capabilities of Johnson & Johnson as we collaborate to drive innovation.
JJDC finds transformative ideas and helps nurture and mature them into real solutions for today’s patients.
Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations.
We invest across sectors—pharmaceuticals, medical devices and consumer healthcare—and at all stages, from new company creation and seed-level startups to Series A and beyond, including private investments in public equity (PIPEs).
All of our portfolio companies receive the same unwavering commitment. We take a long-term approach, deploying the full capabilities of Johnson & Johnson, one of the world’s largest healthcare companies. This includes early science and technology innovation, clinical development, regulatory affairs, manufacturing, reimbursement strategies and commercialization. All of our portfolio companies receive the same unwavering commitment from us, to translate science and technology into patient benefit.
Our team includes diverse leaders with healthcare and technology expertise and deep R&D, business and investment experience. It’s this insight that helps us understand the needs of entrepreneurs and ensures we can offer the support they need at the right time.
Every opportunity is unique, with tailored roles and terms that provide the best path to success.